Weight Change and the Risk of Chronic Pain Following Hip and Knee Arthroplasties

NCT ID: NCT06024161

Last Updated: 2023-09-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

6400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-01

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is a nationwide, register-based cohort survey study. The objective of this study is to investigate whether weight change is associated with the incidence of persistent postoperative pain following total hip arthroplasty and knee arthroplasty across non-obese and obese and patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Persistent Postsurgical Pain Arthritis Knee Arthropathy of Knee Arthropathy of Hip Weight Loss Weight Gain Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Weight gainers

Weight gain 11-15 months after arthroplasty

Weight gain

Intervention Type OTHER

≥5% weight gain

Weight losers

Weight loss11-15 months after arthroplasty

Weight loss

Intervention Type OTHER

≥5% weight loss after arthroplasty

Weight unchanged

Weight unchanged 11-15 months after arthroplasty

Weight unchanged

Intervention Type OTHER

\<5% weight change after arthroplasty

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Weight gain

≥5% weight gain

Intervention Type OTHER

Weight loss

≥5% weight loss after arthroplasty

Intervention Type OTHER

Weight unchanged

\<5% weight change after arthroplasty

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Patients operated with primary hip or knee arthroplasty for osteoarthritis 11-15 months before survey distribution

Exclusion Criteria

* Legally incompetent citizens, i.e., persons with a legal guardian, will not be asked to participate.
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bispebjerg Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Saber Muthanna Saber

MD, PhD fellow

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Søren Overgaard, MD,DMSc,Prof

Role: STUDY_DIRECTOR

Department of orthopedic surgery, Bispebjerg University Hospital, Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Saber M. Saber, MD

Role: CONTACT

004521299265

Jens Laigaard, MD

Role: CONTACT

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

p-2023-14578

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.